Pathophysiology of Thalassemia
Thalassemia results from inherited mutations that reduce or eliminate globin chain synthesis, creating a critical imbalance between alpha and beta globin chains that drives the disease through two primary mechanisms: accumulation of unpaired globin chains that precipitate and destroy red blood cells, and profound ineffective erythropoiesis with hemolytic anemia. 1
Genetic Basis
- Beta-thalassemia is caused by mutations in the HBB gene on chromosome 11, with over 200 disease-causing mutations identified, predominantly single nucleotide substitutions, small deletions, or insertions 2, 3, 4
- Mutations result in either β+ (reduced production) or β0 (complete absence) of beta-globin chain synthesis 2
- Alpha-thalassemia results from reduced or absent synthesis of alpha-globin chains, most commonly in individuals of Southeast Asian descent 5, 6
- The condition follows autosomal recessive inheritance, requiring homozygosity or compound heterozygosity for severe disease 2
Core Pathophysiologic Mechanisms
Primary Defect: Globin Chain Imbalance
- The fundamental problem is defective biosynthesis of one or more globin chain subunits, creating an imbalance in globin chain production 1
- In beta-thalassemia, the absence or reduction of beta chains leads to excess unpaired alpha chains 1, 4
- These unpaired globin chains are insoluble and precipitate within developing erythroblasts and mature erythrocytes 1
Consequences of Chain Precipitation
- Precipitated chains cause direct damage and destruction of developing erythroblasts in the bone marrow, producing ineffective erythropoiesis 1
- Precipitated chains also damage mature red blood cells, causing hemolytic anemia 1, 6
- The clinical severity directly correlates with the extent of imbalance between alpha and non-alpha globin chains 4
Clinical Expression Timeline
- Infants are healthy at birth because fetal hemoglobin (HbF, composed of α2γ2 chains) does not require beta-globin chains 2, 3
- Symptoms emerge at approximately 1-2 years of age as fetal hemoglobin production declines and the switch to adult hemoglobin (requiring beta chains) occurs 2, 3
- Beta-thalassemia major becomes life-threatening by age 1-2 years without intervention 3
Secondary Pathophysiologic Complications
Bone Marrow Response
- Ineffective erythropoiesis and hemolytic anemia trigger chronic bone marrow overstimulation attempting to compensate for the anemia 7
- This leads to skeletal abnormalities during infancy in severe cases 6
Transfusion-Related Iron Overload
- Each unit of transfused blood contains approximately 200-250 mg of elemental iron 2, 3
- Humans lack physiological mechanisms for iron excretion, leading to progressive iron accumulation 2
- Cardiac iron loading becomes the leading cause of death, accounting for approximately 70% of mortality in transfusion-dependent patients 2, 3
- Before modern chelation therapy, patients died by age 10 from cardiac complications; now survival into the 7th decade is possible with optimal care 3
Spectrum of Disease Severity
Beta-Thalassemia Trait (Heterozygous)
- Clinically asymptomatic with specific hematological features 4
- Characterized by microcytic hypochromic anemia that does NOT respond to iron supplementation, with MCV typically <80 fL 8, 3
- Patients have normal life expectancy 6
Beta-Thalassemia Major (Homozygous)
- Requires more than 8 transfusion events per year in adults over 16 years of age 2, 3
- Causes severe transfusion-dependent anemia with hemolytic anemia, poor growth, and skeletal abnormalities 4, 6
- Requires lifelong regular red blood cell transfusions for survival and lifelong iron chelation therapy 2
Alpha-Thalassemia Major
- Severe hemolytic anemia typically leads to hydrops fetalis and fetal demise 5